KIMBERLY BURK: Open Payments
NPI 1588335756 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$19,222 in 278 payments from 26 companies in 2025. Trend: 2023 $2,224 · 2024 $3,636 · 2025 $19,222
Speaker / faculty: $14,063Food & beverage: $4,920Travel & lodging: $240
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 113 | $15,759 |
| Lundbeck LLC | 29 | $420 |
| Eisai Inc. | 15 | $381 |
| Teva Pharmaceuticals USA, Inc. | 17 | $265 |
| Alexion Pharmaceuticals, Inc. | 6 | $252 |
| PFIZER INC. | 19 | $244 |
| LivaNova USA, Inc. | 3 | $243 |
| UCB, Inc. | 12 | $242 |
| CATALYST PHARMACEUTICALS, INC. | 7 | $179 |
| JAZZ PHARMACEUTICALS INC. | 5 | $157 |
Products named: QULIPTA, UBRELVY, VYEPTI, Leqembi, AUSTEDO XR, ULTOMIRIS, NURTEC ODT, VNS THERAPY SENTIVA MODEL 1000 GENERATOR.
Industry payments across IN — which companies pay providers there.
